Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The choline transporter is a membrane protein responsible for the uptake of choline into cells, particularly neurons that synthesize acetylcholine. There are several types of choline transporters, including the high-affinity choline transporter (CHT1/SLC5A7) primarily found in cholinergic neurons, choline transporter-like protein 1 (CTL1) which is an intermediate-affinity, Na+-independent transporter and choline transporter-like protein 2 (CTL2) which is a low-affinity transporter highly expressed on mitochondrial membranes. FLVCR2 is also identified as a primary brain choline importer at the blood-brain barrier. These transporters play crucial roles in maintaining adequate levels of acetylcholine, neurotransmission, and cellular metabolism. Inhibitors like Hemicholinium-3 (HC-3) can block choline transport, impairing acetylcholine synthesis.
Competitive inhibition of choline transport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Choline Transporter (ChT).